by The global Biological Seed Treatment Market is estimated to be valued at US$ 1097.8 million in 2022 and is expected to exhibit a CAGR of 8.10% over the forecast period (2023-2030), as highlighted in a new report published by Coherent Market Insights.
Market Overview:
Biological seed treatment involves the use of microorganisms or natural substances to protect seeds from diseases and pests. It offers advantages such as improved crop yield, enhanced plant health, and reduced environmental impact compared to chemical seed treatments. With the increasing awareness about sustainable farming practices and the adverse effects of chemical seed treatments on the environment, the demand for biological seed treatment is on the rise. Farmers are increasingly adopting these treatments to ensure the health and productivity of their crops.
Market key trends:
One key trend in the biological seed treatment market is the adoption of plant growth-promoting rhizobacteria (PGPR) for seed treatment. These beneficial bacteria colonize the rhizosphere of plants and improve nutrient availability, root development, and overall plant health. PGPR-based seed treatments offer multiple benefits, including enhanced nutrient uptake, increased tolerance to abiotic stress, and protection against pathogens. This trend is driven by the growing need for sustainable agricultural practices and the desire to reduce chemical inputs. The use of PGPR-based seed treatments is expected to witness significant growth in the coming years as farmers embrace more sustainable and environmentally friendly methods of crop production.
Porter’s Analysis
Threat of New Entrants: The biological seed treatment market has a moderate threat of new entrants. While the capital requirements to set up a seed treatment facility may be high, there is still room for new players to enter the market. However, established companies already have a strong foothold and brand recognition, making it challenging for new entrants to penetrate the market.
Bargaining Power of Buyers: The bargaining power of buyers in the biological seed treatment market is relatively high. Buyers have a wide range of options when it comes to choosing seed treatment products and can easily switch suppliers if they are not satisfied with the offerings or prices. This puts pressure on companies to provide high-quality products at competitive prices to retain customers.
Bargaining Power of Suppliers: The bargaining power of suppliers in the biological seed treatment market is moderate. While there are numerous suppliers of active ingredients and biological agents used in seed treatments, the market is highly competitive, giving buyers the advantage of negotiating lower prices. However, suppliers with unique or patented products may have more leverage in terms of pricing and availability.
Threat of New Substitutes: The threat of new substitutes in the biological seed treatment market is relatively low. Biological seed treatments are becoming increasingly popular due to their environmentally friendly nature and effectiveness in protecting crops from diseases and pests. It would be challenging for new substitutes to match the performance and sustainability of biological seed treatments.
Competitive Rivalry: The competitive rivalry in the biological seed treatment market is intense. Key players in the market, such as BASF SE, Bayer Cropscience AG, and Syngenta AG, have a strong presence and compete fiercely with each other to gain market share. Innovations in technology and product offerings, along with extensive distribution networks, are key strategies employed by these players to stay ahead in the competition.
Key Takeaways
The global Biological Seed Treatment Market Share is expected to witness high growth, exhibiting a CAGR of 8.10% over the forecast period (2023-2030). The increasing demand for sustainable agricultural practices and the growing awareness of the harmful effects of chemical pesticides are driving the market’s growth. Biological seed treatments offer an eco-friendly alternative to conventional seed treatments, leading to their widespread adoption.
In terms of regional analysis, North America is expected to be the fastest-growing and dominating region in the biological seed treatment market. The region has a strong focus on sustainable agriculture and is witnessing an increased adoption of biological seed treatments. Moreover, stringent regulations on chemical-based seed treatments in North America are further promoting the use of biological alternatives.
Key players operating in the biological seed treatment market include BASF SE, Bayer Cropscience AG, Bioworks Inc., Syngenta AG, Agrauxine by Lesaffre, Germains Seed Technology, Koppert Biological Systems, Novozymes, Marrone Bio Innovations, and Groundwork BioAg. These companies are investing in research and development activities to introduce new and improved biological seed treatment products. Furthermore, partnerships and collaborations with seed manufacturers and distributors are some of the strategies employed by key players to expand their market share.
In conclusion, the biological seed treatment market is poised for significant growth in the coming years. Market players need to focus on innovation, product differentiation, and expanding their distribution network to remain competitive in this fast-evolving industry.
*Note:
- Source: Coherent Market Insights, Public sources, Desk research
- We have leveraged AI tools to mine information and compile it
Money Singh is a seasoned content writer with over four years of experience in the market research sector. Her expertise spans various industries, including food and beverages, biotechnology, chemical and materials, defense and aerospace, consumer goods, etc.
